Dr Onisha Patel
@dr_opatel
Business Development @wehi_research | First Believer @startmate | Ex-scientist | achievements=Momelotinib, MR1MAIT |Artist|#SuperstarsOfSTEM|🇮🇳 🇦🇺|my views
ID:896625330336571392
https://au.linkedin.com/in/dropatel 13-08-2017 06:51:52
5,9K Tweets
2,4K Followers
3,5K Following
A fantastic achievement for a home-grown Australian discovery. Congrats to WEHI #structuralbiologists , Isa Lucet Dr Onisha Patel for their contribution to structure-based #drugdiscovery of #momelotinib during their time at Monash University in partnership with Cytopia. #WomenInScience
A shining example of innovation, showcasing the power of integrating structural biology in early drug discovery and academia/industry partnership. Kudos to the incredible teams at Monash & Cytopia. Special shoutout to the many women involved #WomenInScience
Massive turnout for #Yes23 at Melbourne today.
The walk stretched from the State Library to Federation square.
Was joined by Dr Muneera Bano | منیرہ بانو and Dr Onisha Patel
Missed catching up with you, Nisha Khot (She/Her)
GSK U.S. FDA 20 years ago, I kicked off a Structural Biology Program in Prof. Jamie Rossjohn lab on JAK kinases with Cytopia, Andrew Wilks, lead chemist Chris Chris Burns & a stellar team Dr Onisha Patel & others. Witnessing JAK inhibitor #momelotinib gaining approval fills me with immense pride.
From LAB to PATIENTS. Great to be part of a team with Andrew Wilks Chris Burns Isa Lucet +others on discovering #momelotinib at a little known Melbourne #drugdiscovery startup Cytopia back in early 2000. Now approved by U.S. FDA for #myelofibrosis patients with anaemia 🎉 🎉🎉
Researchers uncover crucial interactions between PEAK pseudokinases & key signalling proteins controlling cell migration – a crucial step towards identifying new cancer therapeutics. Published in Nature Communications. WEHI (Walter and Eliza Hall Institute) Isa Lucet Michael Roy Dr Onisha Patel.
nature.com/articles/s4146…
Thrilled about our latest Pseudokinase research online today in Nature Communications, providing in depth insights into PEAK pseudokinases interaction with key cancer signalling regulators 14-3-3, Grb2 and CrkII. rdcu.be/deQ7o
Congratulations on your nature paper Rhys Grinter, Ashleigh Kropp, Chris Greening et al. What an achievement and exciting discovery!!!
theage.com.au/national/elect…
Excited to share our recent paper detailing the development of the affinity-directed phosphatase ( #AdPhosphatase ) system for targeted protein #dephosphorylation 🎯
.
cell.com/cell-chemical-…
.
Gopal Sapkota Sapkota Lab Sapkota Lab UoD Life Sciences
Finally TYK2 from the good old JAK family worth upto $6B! Takeda acquires Nimbus Therapeutics allosteric TYK2 inhibitor, potential to be a best-in-class medicine in multiple disease areas. Congratulations team at Nimbus. cc Chris Burns Isa Lucet Jeff Babon James Murphy
So excited WEHI (Walter and Eliza Hall Institute) is part of this new company!! Innovative biotechnology founded on quality research.
'This project has involved more than 30 people at WEHI (Walter and Eliza Hall Institute) & more than 50 in the pharma company. I would also like to thank and acknowledge this large team of collaborators.'
Prof Alan Cowman AC upon winning the CSL Florey Medal for his contributions in malaria research.
A world-first report, 'Artificial Intelligence for Science' has analysed the impact of AI on scientific discovery, finding scientists are adopting the technology at an unprecedented rate 🧠 📈
Read the report here: bit.ly/3EUPPYh
#artificialintelligence #AIAustralia
BREAKING: Our Free Trade Agreement with India has passed through parliament. (📷 with Narendra Modi at the G20)
AI leader Prof @DidarZowghi has been announced as an Advisor for next year's Women in AI Asia Pacific awards💡 Please join us in congratulating her!
Prof Zowghi is a driving force behind our Diversity & Inclusion in AI research program & a renowned info tech educator.
WINNER of LSQ QIMR BERGHOFER WOMAN OF INFLUENCE AWARD Prof Kate Schroder at Institute for Molecular Bioscience developing drug targets for inflammasomes & startup Inflazome. The $620M sale to Roche is Australia’s largest academic deal. Thankyou to sponsor @QIMRBerghofer
Please RT this exciting opportunity for Scientist Entrepreneur to join our Business Development Office WEHI (Walter and Eliza Hall Institute). A position between the BDO team and scientists to help expedite development of novel cell therapy projects towards the clinic. wehi.wd3.myworkdayjobs.com/en-US/WEHI/job…
